Fluidigm Corporation (NASDAQ:LAB), a company specializing in microfluidic systems for the life sciences industry with a market capitalization of $458 million, has seen its stock price touch a 52-week ...

A device developed by the Institute of Bioengineering of Catalonia and the Research Institute of Hospital del Mar allows replicating tumors and their environment to analyze the response to therapies.